New trough from Tecan to reduce reagent costs
27 January 2011 | By kdm communications limited
New 25 ml trough is designed to reduce waste of valuable reagents in automated liquid handling applications...
List view / Grid view
News
Lundbeck Research USA, Inc. & BioFocus sign compound management agreement
26 January 2011 | By BioFocus
BioFocus has signed a 3 year compound management services agreement with Lundbeck Research USA...
PerkinElmer launches EnSpire® Multimode Plate Reader
25 January 2011 | By Edelman
First to combine optical label-free technology & traditional labeled assays to accurately identify potential new therapeutic targets...
EMD Millipore announces change in supply chain of insulin for cell culture media
25 January 2011 | By Novo Nordisk
EMD Millipore, announced an agreement with Novo Nordisk, to transfer the distribution of recombinant human insulin for cell culture media...
Tecan launches innovative HydroSpeed™ plate washer
25 January 2011 | By kdm communications limited
An advanced system for optimized washing of cells, beads and ELISAs in 96- and 384-well formats...
Amgen to Acquire BioVex, a Privately Held Biotechnology Company Headquartered in Woburn, Mass
24 January 2011 | By Amgen
Amgen announced that the companies have entered into a definitive acquisition agreement under which Amgen is to acquire BioVex Group...
GlaxoSmithKline announces start of two phase III studies in advanced/metastatic melanoma
24 January 2011 | By GlaxoSmithKline
GlaxoSmithKline announced the start of two global Phase III studies in advanced or metastatic melanoma patients with a BRAF V600 mutation...
Novartis announces agreement to acquire Genoptix, Inc. in all cash offer
24 January 2011 | By Novartis
Novartis announced today that it has entered into a definitive agreement for the acquisition of Genoptix, Inc...
Novartis gains approval for Gilenya® as a first-line disease modifying oral therapy for multiple sclerosis in Switzerland and Australia
24 January 2011 | By Novartis
Swissmedic and TGA have granted approval for Gilenya® (fingolimod)...
AstraZeneca Replies To The US FDA Complete Response Letter For BRILINTA (Ticagrelor Tablets)
21 January 2011 | By AstraZeneca
AstraZeneca announced it has replied to the US FDA Complete Response Letter received for the ticagrelor (BRILINTA) New Drug Application...
Cognizant Selected by Lilly to Deliver Commercial Operations Solutions to Enhance Sales and Marketing Effectiveness, Business Performance
20 January 2011 | By Brands2Life
Cognizant, announced that it has been selected by Eli Lilly and Company...
Merck KGaA and Lead Discovery Center Enter Collaboration for the Discovery of Anti-Cancer Compounds
20 January 2011 | By Merck Serono
Merck Serono, announced today that Merck KGaA has signed a cooperation agreement with the Lead Discovery Center GmbH (LDC)...
Statement from Lilly and Avid on FDA Advisory Committee Recommendation for Amyvid(TM) (Florbetapir) NDA
20 January 2011 | By Eli Lilly and Company
The U.S. FDA Peripheral and Central Nervous System Drugs Advisory Committee decided today that it could not recommend approval of Amyvid™ (florbetapir) at this time...
Erbitux Long-Term Survival Benefit for mCRC Patients Confirmed With FOLFOX
19 January 2011 | By Merck KGaA
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today highlighted a further analysis of the large randomized Phase II OPUSa study...
Public/private partnership improves UK’s clinical research competitiveness
18 January 2011 | By National Institute for Health Research
A new report shows collaboration between the life sciences industry, the NHS and the National Institute for Health Research (NIHR) Clinical Research Network...
